RKT - RKT CRWD among premarket losers September, 03 2020 08:26 AM Rocket Companies Inc. Class A Akebia Therapeutics (NASDAQ:AKBA) -69% after vadadustat misses safety endpoints in late-stage studies in CKD anemia.More news on: Akebia Therapeutics, Inc., Zuora, Inc., PagerDuty, Inc., Stocks on the move, , Read more ...